Replies to post #18968 on Mymetics Corp (MYMX)

[Work Harder]

Ditto eom

[Work Harder]

Ragweed Pollen Allergy Treatment Market In-deep Analysis and Latest Clinical Advanced Treatment Outlook – 2026 | ALK-Abello A/S, Anergis SA, ASIT Biotech SA, Astellas Pharma Inc

https://www.marketwatch.com/press-release/ragweed-pollen-allergy-treatment-market-in-deep-analysis-and-latest-clinical-advanced-treatment-outlook-2026-alk-abello-as-anergis-sa-asit-biotech-sa-astellas-pharma-inc-2020-07-04?tesla=y

We are aiming to develop drug to cure allergic diseases

Th 1 and Th 2 Immune respond

https://www.astellas.com/system/files/CSP_2018_En_0.pdf

Astellas Announces FDA Fast Track Designation for Peanut Allergy
JUNE 15, 2017

https://www.immunomix.com/astellas-peanut-fast-track/

Not that they would go there again

https://newsroom.astellas.us/feature-stories?item=1047

LOL no LOL

[Work Harder]

Astellas Pharma & Immunomic Therapeutics Announce $300-Million Worldwide Partnership for LAMP-vax Products

Upon execution of the new agreement, Immunomic Therapeutics will receive an upfront payment of $300 million and be entitled to receive 10% royalties of net sales of the potential products.

https://drug-dev.com/astellas-pharma-immunomic-therapeutics-announce-300-million-worldwide-partnership-for-lamp-vax-products/

ASP0892 is designed to generate a Th1–mediated immune response

https://www.immunomix.com/pipeline/allergy/

DNA VACCINE TECHNOLOGY – A Vaccine Breakthrough That Could Change Lives & Enable Vaccine Development Programs

https://drug-dev.com/dna-vaccine-technology-a-vaccine-breakthrough-that-could-change-lives-enable-vaccine-development-programs/

https://adisinsight.springer.com/drugs/800037023

[Work Harder]

Fast & Soon

https://grantome.com/grant/NIH/UM2-AI130836-01-6393

https://adisinsight.springer.com/drugs/800048527

LOL

Have a good week all

[Work Harder]

Maybe tomorrow

but probably not

LOL

[Work Harder]

So, the Bertarelli's don't want us lowly common holders

to have the data yet

Maybe the Wyss crowd

Both

;?